Radiotherapy & Oncology
Volume 94, Issue 3 , Page 388 , March 2010

Normal Tissue Complication Probability after hypofractionation increased due to the high dose per fraction or the high total Biological Equivalent Dose?

Received 14 January 2010 ,Accepted 29 January 2010.

References 

  1. Hoppe BS, Laser B, Kowalski AV, et al. Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who’s at risk?. Int J Radiat Oncol Biol Phys. 2008;72:1283–1286
  2. Forquer JA, Fakiris AJ, Timmerman RD, et al. Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites2. Radiother Oncol. 2009;93:408–413
  3. Bentzen SM, Joiner MC. The linear-quadratic approach in clinical practice. In:  van der Kogel AJ,  Joiner MC editor. Basic clinical radiobiology. 4th ed.. Hodder Arnold; 2009;p. 120–134
  4. Fowler JF, Tome WA, Fenwick JD, et al. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys. 2004;60:1241–1256
  5. Guerrero M, Li XA. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy. Phys Med Biol. 2004;49:4825–4835
  6. Borst GR, Ishikawa M, Nijkamp J et al. Radiation Pneumonitis after hypofractionated radiotherapy: evaluation of the LQ(L) model and different dose parameters. Int J Radiat Oncol Biol Phys; doi:10.1016/j.ijrobp.2009.10.015.
  7. Borst GR, Ishikawa M, Nijkamp J, et al. Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy. Radiother Oncol. 2009;91:307–313
  8. Dorr W. Pathogenesis of normal-tissue side effects. In:  van der Kogel AJ,  Joiner MC editor. Basic clinical radiobiology. 4th ed.. Hodder Arnold; 2009;p. 167–190

PII: S0167-8140(10)00075-7

doi: 10.1016/j.radonc.2010.01.023

Radiotherapy & Oncology
Volume 94, Issue 3 , Page 388 , March 2010

Article Tools